Background and purpose: The insulin-like growth factor binding protein 3 (IGFBP-3) and its
novel death receptor (IGFBP-3R) have been exhibited to have tumor suppressor effects …

Background: Gastric cancer (GC) as one of the most common cancers, serves as the third
cause of cancer-related death. Insulin-like growth factor binding protein 3 (IGFBP-3) and its …

Insulin‐like growth factor binding protein‐3 (IGFBP‐3) and its newly discovered death
receptor (IGFBP‐3R) have been reported to involve in a wide variety of cancers. However …

The present study aimed to investigate the expression and prognostic significance of insulin‑
like growth factor binding protein 6 (IGFBP-6) in gastric adenocarcinoma. The expression of …

Increasing evidence indicated that insulin-like growth factor binding protein 7 (IGFBP7) was
regarded as a potential tumor suppressor in various human cancers, but its role in gastric …

Background/Aim: The clinicopathological significance and prognostic value of insulin-like
growth factor binding protein 1 (IGFBP1) in gastric cancer have not been investigated to …

Insulin-like growth factor binding protein-3 (IGFBP-3) is a multi-functional protein known to
induce apoptosis of various cancer cells in an insulin-like growth factor (IGF)-dependent and …

Aim: IGF binding protein-3 (IGFBP-3) displays growth inhibitory/proapoptotic action and
counteracts the IGF-1 tumor-promoting effects by downregulating its bioavailability. We …

Aims Insulin-like growth factor binding protein 7 (IGFBP7) is reported to have tumour
suppressor function through an IGF-dependent pathway in various malignant tumours …

Insulin-like growth factor-binding protein-3 (IGFBP-3), a major regulator of endocrine actions
of IGFs, is a p53-regulated potent apoptotic factor and is significantly suppressed in a variety …